These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8655918)
1. The pH dependence of interleukin-1 beta effects on insulin secretion in HIT cells. Shimizu H; Uehara Y; Sato N; Mori M; Shimomura Y J Endocrinol Invest; 1995 Sep; 18(8):603-7. PubMed ID: 8655918 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation. Sjöholm A FEBS Lett; 1991 Sep; 289(2):249-52. PubMed ID: 1655527 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion. Green IC; Delaney CA; Cunningham JM; Karmiris V; Southern C Diabetologia; 1993 Jan; 36(1):9-16. PubMed ID: 7679657 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets. Shimizu H; Okajima F; Kimura T; Ohtani K; Tsuchiya T; Takahashi H; Kuwabara A; Tomura H; Sato K; Mori M Endocr J; 2000 Jun; 47(3):261-9. PubMed ID: 11036869 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1. Southern C; Schulster D; Green IC Biochem J; 1990 Nov; 272(1):243-5. PubMed ID: 2264829 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Comens PG; Wolf BA; Unanue ER; Lacy PE; McDaniel ML Diabetes; 1987 Aug; 36(8):963-70. PubMed ID: 3297891 [TBL] [Abstract][Full Text] [Related]
7. Glucagon plays an important role in the modification of insulin secretion by leptin. Shimizu H; Tsuchiya T; Ohtani K; Shimomura K; Oh-I S; Ariyama Y; Okada S; Kishi M; Mori M Islets; 2011; 3(4):150-4. PubMed ID: 21623172 [TBL] [Abstract][Full Text] [Related]
8. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662 [TBL] [Abstract][Full Text] [Related]
9. Effects of monensin on metabolism of isolated rat islets of Langerhans. Smith JE; Howell SL Biochem J; 1984 Oct; 223(2):423-32. PubMed ID: 6388569 [TBL] [Abstract][Full Text] [Related]
10. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F. Cunningham JM; Mabley JG; Delaney CA; Green IC Mol Cell Endocrinol; 1994 Jun; 102(1-2):23-9. PubMed ID: 7926270 [TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function. Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion. Zawalich WS; Zawalich KC; Rasmussen H Endocrinology; 1989 May; 124(5):2350-7. PubMed ID: 2539976 [TBL] [Abstract][Full Text] [Related]
13. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Corbett JA; McDaniel ML Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870 [TBL] [Abstract][Full Text] [Related]
14. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells. Ohtani KI; Shimizu H; Sato N; Mori M Endocrinology; 1998 Jan; 139(1):172-8. PubMed ID: 9421412 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Hughes JH; Easom RA; Wolf BA; Turk J; McDaniel ML Diabetes; 1989 Oct; 38(10):1251-7. PubMed ID: 2507377 [TBL] [Abstract][Full Text] [Related]
16. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets. Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861 [TBL] [Abstract][Full Text] [Related]
17. Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of Langerhans. Belin VD; Mabley JG; James RF; Swift SM; Clayton HA; Titheradge MA; Green IC Cytokine; 1999 Aug; 11(8):585-92. PubMed ID: 10433805 [TBL] [Abstract][Full Text] [Related]
18. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism. Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413 [TBL] [Abstract][Full Text] [Related]
19. Dexamethasone attenuates altered insulin secretion elicited by interleukin-1 beta in HIT cells. Shimizu H; Uehara Y; Sato N; Shimomura Y; Mori M; Kobayashi I Eur J Pharmacol; 1992 Nov; 222(2-3):279-82. PubMed ID: 1451738 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. Southern C; Schulster D; Green IC FEBS Lett; 1990 Dec; 276(1-2):42-4. PubMed ID: 2265709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]